Increased COVID-19 Mortality in People With Previous Cerebrovascular Disease: A Population-Based Cohort Study
Author(s) -
Uxue Lazcano,
Elisa CuadradoGodia,
María Grau,
Isaac Subirana,
Elisenda Martínez,
Marc Boher-Massaguer,
Ana Rodríguez-Campello,
Eva GiraltSteinhauer,
Isabel Fernández,
Jordi Jiménez-Conde,
Jaume Roquer,
Ángel Ois
Publication year - 2021
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.121.036257
Subject(s) - medicine , stroke (engine) , atrial fibrillation , hazard ratio , population , subarachnoid hemorrhage , cohort , proportional hazards model , kidney disease , diabetes mellitus , cardiology , confidence interval , mechanical engineering , environmental health , engineering , endocrinology
Background: The aim of the study was to determine the association between previous stroke and mortality after coronavirus disease 2019 (COVID-19) according to sex, age groups, and stroke subtypes. Methods: Prospective population-based cohort study including all COVID-19 positive cases between February 1 and July 31, 2020. Comorbidities and mortality were extracted using linked health administration databases. Previous stroke included transient ischemic attack, ischemic stroke, hemorrhagic stroke, spontaneous subarachnoid hemorrhage, and combined stroke for cases with more than one category. Other comorbidities were obesity, diabetes, hypertension, ischemic heart disease, atrial fibrillation, heart failure, chronic obstructive pulmonary disease, chronic kidney disease, cirrhosis, dementia, individual socioeconomic index, and deprivation index. Cases were followed up until December 31, 2020. Primary outcome was mortality of any cause after COVID-19 positivity. Cox proportional regression analysis adjusted for comorbidities was used. Stratified analyses were performed for sex and age (<60, 60–79, and ≥80 years). Results: There were 91 629 COVID-19 cases. Previous strokes were 5752 (6.27%), of which 3887 (67.57%) were ischemic, 1237 (21.50%) transient ischemic attack, 255 (4.43%) combined, 203 (3.53%) hemorrhagic, and 170 (2.96%) subarachnoid hemorrhage. There were 9512 deaths (10.38%). Mortality was associated with previous stroke (hazard ratio [HR]=1.12 [95% CI, 1.06–1.18];P <0.001), in both sexes separately (men=1.13 [1.05–1.22];P =0.001; women=1.09 [1.01–1.18];P =0.023), in people <60 years (HR=2.97 [1.97–4.48];P <0.001) and 60 to 79 years (HR=1.32 [1.19–1.48];P <0.001) but not in people ≥80 years (HR=1.02 [0.96–1.09];P =0.437). Ischemic (HR=1.11 [1.05–1.18];P =0.001), hemorrhagic (HR=1.53 [1.20–1.96];P =0.001) and combined (HR=1.31 [1.05–1.63];P =0.016) strokes were associated but not transient ischemic attack. Subarachnoid hemorrhage was associated only in people <60 years (HR=5.73 [1.82–18.06];P =0.003).Conclusions: Previous stroke was associated with a higher mortality in people younger than 80 years. The association occurred for both ischemic and hemorrhagic stroke but not for transient ischemic attack. These data might help healthcare authorities to establish prioritization strategies for COVID-19 vaccination.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom